Location of Primary Tumor Is Important Prognostic Factor in Colon Cancer

Share this content:
Whether the primary tumor is left- or right-sided should be considered when adjusting for treatment among patients with colon cancer.
Whether the primary tumor is left- or right-sided should be considered when adjusting for treatment among patients with colon cancer.

Whether the primary tumor is left- or right-sided should be considered when adjusting for treatment among patients with colon cancer regardless of disease stage, according to a study published in JAMA Oncology.1

Italian researchers led by Fausto Petrelli, MD, conducted a meta-analysis of 66 prospective and retrospective studies that included data on 1,437,846 patients. The goal was to compare overall survival between patients with left-sided and right-sided colon cancers, noting that the location of tumors has emerged as an important factor for prognosis.

The researchers evaluated for overall survival using prognostic data related to tumor location. The analysis found that patients with a primary tumor located on the left side had a significantly lower risk of death. This result was independent of factors such as stage, race, and number of participants in the included studies.

RELATED: Circulating Tumor DNA May Accurately Predict Recurrence of Colon Cancer

The authors conclude that the side of colon cancer “should be considered when deciding treatment intensity in metastatic settings, and should represent a stratification factor for future adjuvant studies.”

Reference

  1. Petrelli F, Tomasello G, Borgonovo K, et al. Prognostic survival associated with left-sided vs right-sided colon cancer. JAMA Oncol. 2016 Oct 27. doi:10.1001/jamaoncol.2016.4227 [Epub ahead of print]

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs